Radiotherapy and the gut microbiome: facts and fiction

[1]  J. Petrosino,et al.  Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer , 2021 .

[2]  W. Makarewicz,et al.  Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics , 2020, Gut microbes.

[3]  Saijun Fan,et al.  Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein , 2020, Microbiome.

[4]  B. Subhadra,et al.  Colorectal Cancer and Probiotics: Are Bugs Really Drugs? , 2020, Cancers.

[5]  J. Park,et al.  Gut microbiome composition is associated with a pathologic response after preoperative chemoradiation in rectal cancer patients. , 2020, International journal of radiation oncology, biology, physics.

[6]  J. Bou Khalil,et al.  Full-repertoire comparison of the microscopic objects composing the human gut microbiome with sequenced and cultured communities , 2020, Journal of Microbiology.

[7]  Bota Cui,et al.  Fecal microbiota transplantation: A promising treatment for radiation enteritis? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  J. O’Sullivan,et al.  Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers , 2020, Nature Reviews Gastroenterology & Hepatology.

[9]  J. Petrosino,et al.  Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer. , 2020, International journal of radiation oncology, biology, physics.

[10]  S. Chan.  Microbiome and cancer treatment: Are we ready to apply in clinics? , 2020, Progress in molecular biology and translational science.

[11]  F. Bushman,et al.  Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. , 2019, The Journal of clinical investigation.

[12]  A. Santerre,et al.  Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis , 2019, Probiotics and Antimicrobial Proteins.

[13]  Wantong Song,et al.  Nanotechnology intervention of the microbiome for cancer therapy , 2019, Nature Nanotechnology.

[14]  R. Weigel,et al.  Randomized Trial of Perioperative Probiotics among Patients Undergoing Major Abdominal Operation. , 2019, Journal of the American College of Surgeons.

[15]  A. Russo,et al.  Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. , 2019, Critical reviews in oncology/hematology.

[16]  Fatemeh Zununi Vahed,et al.  The impact of tumor and gut microbiotas on cancer therapy; Beneficial or detrimental? , 2019, Life sciences.

[17]  Jeong-Seok Nam,et al.  The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance , 2019, Journal of Experimental & Clinical Cancer Research.

[18]  M. Liss,et al.  The Microbiome and Prostate Cancer Risk , 2019, Current Urology Reports.

[19]  E. Jacobs,et al.  The Association between Prebiotic Fiber Supplement Use and Colorectal Cancer Risk and Mortality in the Women's Health Initiative , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[20]  D. Lobo,et al.  Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery , 2019, Annals of surgery.

[21]  R. Sidman,et al.  Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer , 2019, Proceedings of the National Academy of Sciences.

[22]  Christine B. Peterson,et al.  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.

[23]  A. Linge,et al.  SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed , 2019, Autophagy.

[24]  I. Kareva.  Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review , 2019, Stem cells.

[25]  Kevin S. Bonham,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[26]  Xu Zhang,et al.  Perspective and Guidelines for Metaproteomics in Microbiome Studies. , 2019, Journal of proteome research.

[27]  H. Le,et al.  Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis , 2019, Expert review of gastroenterology & hepatology.

[28]  Paul Theodor Pyl,et al.  Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.

[29]  S. Umar,et al.  The Duplex Interaction of Microbiome with Chemoradiation and Immunotherapy: Potential Implications for Colorectal Cancer , 2019, Current Colorectal Cancer Reports.

[30]  Tal Danino,et al.  Programmable bacteria induce durable tumor regression and systemic antitumor immunity , 2019, Nature Medicine.

[31]  B. Helmink,et al.  The microbiome, cancer, and cancer therapy , 2019, Nature Medicine.

[32]  A. Abdollahi,et al.  The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity , 2019, Clinical Cancer Research.

[33]  Harris H. Wang,et al.  Metagenomic engineering of the mammalian gut microbiome in situ , 2018, Nature Methods.

[34]  S. Gately.  Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients. , 2019, Cancer treatment and research.

[35]  J. Younes,et al.  Pre-, pro- and synbiotics in cancer prevention and treatment—a review of basic and clinical research , 2018, Ecancermedicalscience.

[36]  S. Haase,et al.  Impacts of microbiome metabolites on immune regulation and autoimmunity , 2018, Immunology.

[37]  P. Saris,et al.  Innovative approaches to nisin production , 2018, Applied Microbiology and Biotechnology.

[38]  Jean Paul Thiery,et al.  Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention , 2018, Nature Biomedical Engineering.

[39]  J. Ravel,et al.  Improving regulation of microbiota transplants , 2017, Science.

[40]  Donna Neuberg,et al.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.

[41]  Luis Pedro Coelho,et al.  Subspecies in the global human gut microbiome , 2017, Molecular systems biology.

[42]  P. Tso,et al.  Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease , 2017, Front. Immunol..

[43]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[44]  David A. Drew,et al.  Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue , 2017, JAMA oncology.

[45]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics ( ISAPP ) consensus statement on the definition and scope of prebiotics , 2018 .

[46]  Y. Shu,et al.  Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials , 2017, PloS one.

[47]  Bangmao Wang,et al.  Secondary bile acid‐induced dysbiosis promotes intestinal carcinogenesis , 2017, International journal of cancer.

[48]  Soumen Roy,et al.  Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.

[49]  Y. Kashi,et al.  Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction , 2017, Gut.

[50]  C. Danjoux,et al.  Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[51]  Ian D. Wilson,et al.  Gut microbiota modulation of chemotherapy efficacy and toxicity , 2017, Nature Reviews Gastroenterology &Hepatology.

[52]  R. Sleator,et al.  Engineered Probiotics: Applications and Biological Containment. , 2017, Annual review of food science and technology.

[53]  Junling Zhang,et al.  Faecal microbiota transplantation protects against radiation‐induced toxicity , 2017, EMBO molecular medicine.

[54]  A. Freifeld,et al.  Clostridium difficile-Associated Diarrhea in the Oncology Patient. , 2017, Journal of oncology practice.

[55]  F. Cappello,et al.  The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping. , 2017, Journal of biological regulators and homeostatic agents.

[56]  V. Azevedo,et al.  Anti‐cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL‐10 in a colorectal cancer mouse model , 2017, International immunopharmacology.

[57]  Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells , 2016, BMC Cancer.

[58]  B. Deng,et al.  Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota , 2016, Oncotarget.

[59]  Saijun Fan,et al.  Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity , 2016, International journal of molecular sciences.

[60]  M. Maeda,et al.  Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell. , 2016, Biochemical and biophysical research communications.

[61]  Tytus D. Mak,et al.  An Integrated Multi-Omic Approach to Assess Radiation Injury on the Host-Microbiome Axis , 2016, Radiation Research.

[62]  Muhammad Anis Uddin Nasir,et al.  Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats , 2016, Nutrients.

[63]  R. Yantiss,et al.  Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden , 2016, Cancer Prevention Research.

[64]  W. El-Deiry,et al.  Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation. , 2016, Cancer research.

[65]  M. Hutchinson,et al.  Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms , 2016, Molecular Cancer Therapeutics.

[66]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[67]  B. Krebs.  Prebiotic and Synbiotic Treatment before Colorectal Surgery--Randomised Double Blind Trial. , 2016, Collegium antropologicum.

[68]  G. Jan,et al.  The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer , 2016, Oncotarget.

[69]  P. Langella,et al.  Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer , 2016, Journal of Gastroenterology.

[70]  F. Ginhoux,et al.  Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.

[71]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[72]  P. Cotter,et al.  Faculty Opinions recommendation of Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. , 2015 .

[73]  Pavlos Bousounis,et al.  Bacteriocin production augments niche competition by enterococci in the mammalian GI tract , 2015, Nature.

[74]  Glenn Gibson,et al.  Impact of palm date consumption on microbiota growth and large intestinal health: a randomised, controlled, cross-over, human intervention study , 2015, British Journal of Nutrition.

[75]  Jun Yu,et al.  Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment , 2015, Oncotarget.

[76]  Katie Kingwell.  Bacteriophage therapies re-enter clinical trials , 2015, Nature Reviews Drug Discovery.

[77]  Kavita R Pandey,et al.  Probiotics, prebiotics and synbiotics- a review , 2015, Journal of Food Science and Technology.

[78]  G. Young,et al.  Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial , 2015, British Journal of Nutrition.

[79]  Jinu Kim,et al.  High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. , 2015, Anaerobe.

[80]  T. Cheng,et al.  Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study , 2015, PloS one.

[81]  J. Parkhill,et al.  TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine , 2015, The Journal of Immunology.

[82]  J. Delcour,et al.  Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects. , 2015, The British journal of nutrition.

[83]  N. Naud,et al.  Antibiotic Suppression of Intestinal Microbiota Reduces Heme-Induced Lipoperoxidation Associated with Colon Carcinogenesis in Rats , 2015, Nutrition and cancer.

[84]  David G Besselsen,et al.  The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention , 2014, Inflammatory bowel diseases.

[85]  R. Baskar,et al.  Biological response of cancer cells to radiation treatment , 2014, Front. Mol. Biosci..

[86]  A. Dagnault,et al.  A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. , 2014, Clinical nutrition.

[87]  E. Montassier,et al.  Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications , 2014, Alimentary pharmacology & therapeutics.

[88]  P. Kruzliak,et al.  Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats. , 2014, Rejuvenation research.

[89]  Bas E Dutilh,et al.  Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. , 2014, Omics : a journal of integrative biology.

[90]  A. Molan,et al.  Evaluation of the Effect of Blackcurrant Products on Gut Microbiota and on Markers of Risk for Colon Cancer in Humans , 2014, Phytotherapy research : PTR.

[91]  D. Dearnaley,et al.  Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. , 2014, The Lancet. Oncology.

[92]  S. Massart,et al.  16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation , 2014, Microbial Ecology.

[93]  E. Pamer,et al.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns , 2014, Mucosal Immunology.

[94]  H. Kim,et al.  Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing , 2013, PloS one.

[95]  G. Augustin,et al.  A Randomized Clinical Trial of Synbiotic Treatment before Colorectal Cancer Surgery , 2013, The American surgeon.

[96]  F. Marincola,et al.  Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.

[97]  Eric Vivier,et al.  The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide , 2013, Science.

[98]  Gaurav Agrawal,et al.  Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions , 2013, Current Gastroenterology Reports.

[99]  J. Doré,et al.  ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[100]  R. Jena,et al.  Advances in radiotherapy , 2012, British medical journal.

[101]  D. Jaffray.  Image-guided radiotherapy: from current concept to future perspectives , 2012, Nature Reviews Clinical Oncology.

[102]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[103]  W. Verstraete,et al.  Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines. , 2011, Environmental microbiology.

[104]  Y. Kuwahara,et al.  Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy , 2011, Cell Death and Disease.

[105]  Fiona A. Stewart,et al.  Strategies to improve radiotherapy with targeted drugs , 2011, Nature Reviews Cancer.

[106]  R. Benya,et al.  Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention , 2011, Cancer Prevention Research.

[107]  W. Tissing,et al.  The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis , 2010, PLoS pathogens.

[108]  J. Alsner,et al.  Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[109]  B. Leggett,et al.  A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. , 2009, The American journal of clinical nutrition.

[110]  Alison M. Dunning,et al.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype , 2009, Nature Reviews Cancer.

[111]  C. Manichanh,et al.  The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea , 2008, The American Journal of Gastroenterology.

[112]  S. Sonis,et al.  Management of oral mucositis in patients who have cancer. , 2008, Dental clinics of North America.

[113]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[114]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[115]  J. Gordon,et al.  Microbial regulation of intestinal radiosensitivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[116]  L. Elting,et al.  Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.

[117]  M. Karin,et al.  IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium , 2004 .

[118]  R. Lorenz,et al.  TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[119]  S. Cohn,et al.  Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. , 2000, Gastroenterology.

[120]  Bentzen,et al.  Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.

[121]  M. Lederman.  Advances in radiotherapy. , 1970, The Practitioner.